294
Views
30
CrossRef citations to date
0
Altmetric
Brief Report

Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and 2012

, , , &
Pages 406-410 | Received 04 Sep 2015, Accepted 12 Nov 2015, Published online: 14 Dec 2015

References

  • Berntsson M, Tunback P, Ellstrom A, et al. Decreasing prevalence of herpes simplex virus-2 antibodies in selected groups of women in Sweden. Acta Derm Venereol. 2009;89:623–626.
  • Delaney S, Gardella C, Saracino M, et al. Seroprevalence of herpes simplex virus type 1 and 2 among pregnant women, 1989-2010. JAMA. 2014;312:746–748.
  • Forsgren M, Skoog E, Jeansson S, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS. 1994;5:113–116.
  • Persson K, Mansson A, Jonsson E, Nordenfelt E. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis. 1995;27:195–199.
  • Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2–United States, 1999–2010. J Infect Dis. 2014;209:325–333.
  • Enders G, Daiminger A, Lindemann L, et al. Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010. Med Microbiol Immunol. 2012;201:303–309.
  • Taniguchi K, Watanabe N, Sato A, et al. Changes in cytomegalovirus seroprevalence in pregnant Japanese women–a 10-year single center study. J Clin Virol. 2014;9:192–194.
  • Odland ML, Strand KM, Nordbo SA, et al. Changing patterns of cytomegalovirus seroprevalence among pregnant women in Norway between 1995 and 2009 examined in the Norwegian mother and child cohort study and two cohorts from Sor-Trondelag county: a cross-sectional study. BMJ Open. 2013;3:e003066.
  • Silasi M, Cardenas I, Kwon JY, et al. Viral infections during pregnancy. Am J Reprod Immunol. 2015;73:199–213.
  • Xu F, Markowitz LE, Gottlieb SL, Berman SM. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States. Am J Obstet Gynecol. 2007;196:43.e1–6.
  • Suligoi B, Cusan M, Santopadre P, et al. HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum. Sex Transm Infect. 2000;76:213–214.
  • Kucera P, Gerber S, Marques-Vidal P, Meylan PR. Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study. Eur J Obstet Gynecol Reprod Biol. 2012;160:13–17.
  • Sauerbrei A, Schmitt S, Scheper T, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. Euro Surveill. 2011;16:20005.
  • Arvaja M, Lehtinen M, Koskela P, et al. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect. 1999;75:168–171.
  • Gratacap-Cavallier B, Bosson JL, Morand P, et al. Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol. 1998;14:147–152.
  • Pembrey L, Raynor P, Griffiths P, et al. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One. 2013;8:e81881.
  • Lanzieri TM, Dollard SC, Bialek SR, Grosse SD. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014;22:44–48.
  • Hannachi N, Marzouk M, Harrabi I, et al. Seroprevalence of rubella virus, varicella zoster virus, cytomegalovirus and parvovirus B19 among pregnant women in the Sousse region, Tunisia. Bull Soc Pathol Exot. 2011;104:62–67.
  • Saadatian-Elahi M, Mekki Y, Del Signore C, et al. Seroprevalence of varicella antibodies among pregnant women in Lyon-France. Eur J Epidemiol. 2007;22:405–409.
  • Alanen A, Kahala K, Vahlberg T, et al. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in south-western Finland. BJOG. 2005;112:50–56.
  • Holl K, Surcel HM, Koskela P, et al. Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring: a nested case-control study. APMIS. 2008;116:816–822.
  • Mustonen K, Mustakangas P, Smeds M, et al. Antibodies to varicella zoster virus in the cerebrospinal fluid of neonates with seizures. Arch Dis Child Fetal Neonatal Ed. 1998;78:F57–61.
  • Bernstein DI, Bellamy AR, Hook EW 3rd, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56:344–351.
  • Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics. 2006;117:1955–1962.
  • Pascual A, Moessinger A, Gerber S, Meylan P; Swiss Paediatric Surveillance Unit (SPSU). Neonatal herpes simplex virus infections in Switzerland: results of a 6-year national prospective surveillance study. Clin Microbiol Infect. 2011;17:1907–1910.
  • Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289:203–209.
  • Kortekangas-Savolainen O, Orhanen E, Puodinketo T, Vuorinen T. Epidemiology of genital herpes simplex virus type 1 and 2 infections in southwestern Finland during a 10-year period (2003-2012). Sex Transm Dis. 2014;41:268–271.
  • Management of genital herpes in pregnancy. Royal College of Obstetricians & Gynaecologists; October 2014. Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/genital-herpes/
  • Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis. 2011;52:e11–13.
  • Wikstrom E, Bloigu A, Ohman H, et al. An increasing proportion of reported Chlamydia trachomatis infections are repeated diagnoses. Sex Transm Dis. 2012;39:968–972.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.